Format

Send to

Choose Destination
J Clin Pharmacol. 2017 Apr;57(4):536-537. doi: 10.1002/jcph.844. Epub 2016 Nov 21.

Extracorporeal Clearance of Levetiracetam During Continuous Venovenous Hemofiltration in a Critically Ill Patient and New Dosing Recommendation.

Author information

1
Department of Intensive Care, VieCuri Medical Center, Venlo, The Netherlands.
2
Department of Pharmacology and Toxicology, Maastricht University, Maastricht, The Netherlands.
3
Department of Neurology, VieCuri Medical Center, Venlo, The Netherlands.
4
CAPHRI School of Public Health and Primary Care Maastricht University, Maastricht, The Netherlands.
5
Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, The Netherlands.
6
Department of Hospital Pharmacy, VieCuri Medical Center, Venlo, The Netherlands.

KEYWORDS:

antiepileptic drugs; continuous venovenous hemofiltration; epilepsy; levetiracetam

PMID:
27868207
DOI:
10.1002/jcph.844
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center